Impact of Mutational Status and Prognostic Factors on Survival in Chronic Myelomonocytic Leukemia With Systemic Inflammation and Autoimmune Disorders
Hemasphere
.
2023 Feb 23;7(3):e847.
doi: 10.1097/HS9.0000000000000847.
eCollection 2023 Mar.
Authors
Charles Dussiau
1
,
Henry Dupuy
2
,
Audrey Bidet
1
,
Mathieu Sauvezie
3
,
Anne-Charlotte De-Grande
3
,
Lisa Boureau
1
,
Etienne Riviere
2
,
Edouard Forcade
3
,
Fabrice Bonnet
4
,
Pierre-Yves Dumas
3
,
Pierre Duffau
5
,
Arnaud Pigneux
3
,
Jean-François Viallard
2
,
Sophie Dimicoli-Salazar
3
,
Estibaliz Lazaro
2
Affiliations
1
Department of Hematology Biology, Molecular Hematology, Bordeaux University Hospital, Haut-Levêque Hospital, Pessac, France.
2
Department of Internal Medicine and Infectious Diseases, Bordeaux University Hospital, Haut-Levêque Hospital, Pessac, France.
3
Department of Clinical Hematology and Cell Therapy, Bordeaux University Hospital, Haut-Haut-Levêque Hospital, Pessac, France.
4
Department of Internal Medicine and Infectious Diseases, Bordeaux University Hospital, Saint André Hospital, Bordeaux, France.
5
Department of Internal Medicine and Clinical Immunology, Bordeaux University Hospital, Saint André Hospital, Bordeaux, France.
PMID:
36844177
PMCID:
PMC9953038
DOI:
10.1097/HS9.0000000000000847
No abstract available